Oxford tests new malaria shot in african children
NCT ID NCT06958198
Summary
This early-stage study is testing the safety and immune response of a new malaria vaccine in healthy adults and young children in Burkina Faso. Researchers are giving different combinations of vaccine components to small groups to see which is safest and most promising. The goal is to develop a vaccine that could help prevent malaria, a serious mosquito-borne disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA FALCIPARUM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institut de Recherche en Sciences de la Santé
RECRUITINGSiglé, Boulkiemdé Province, BP 7192 OUAGADOUGOU 03, BF, Burkina Faso
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.